top
Please input keywords
Cooperation Mode
Committed to innovation with partners
01
Licensing of fully human antibody mice
02
Cooperative drug development
03
Flexibility with terms of agreement
Cooperative Organization
Biocytogen has reached strategic partnership with a number of pharmaceutical enterprises around the world for licensing of the fully human antibody mice platform and the subsequent development of antibody drugs, so as to accelerate the marketing of high-quality drugs and benefit patients more quickly.
Headquartered in Beijing, Biocytogen has branches in Haimen Jiangsu, Shanghai, Boston, USA and Heidelberg, Germany. Its wholly-owned subsidiary, Eucure Biopharma, undertakes the mission of clinical development for Biocytogen’s R&D pipelines.
Contact us